Author

Yosuke Kanno

Doshisha Women's College of Liberal Arts Assistant professor - Cited by 1,277 - Fibrosis - Vascular dysfunction

Biography

Dr. Yosuke Kanno  is an Associate professor in the department of Vascular dysfunction Doshisha Women's College of Liberal Arts Assistant professor Kyotanabe, Kyoto, Japan. . His study interests major on Vascular dysfunction. Currently , Dr. Yosuke Kanno  is the author/editors/reviewer in several international journals. He published 5 articles in many journals and the articles are informative and got good citations.
Title
Cited by
Year
123. α2AP をターゲットとした強皮症治療法の開発
123
2016
Structural basis of alternative DNA recognition by Maf transcription factors
H Kurokawa, H Motohashi, S Sueno, M Kimura, H Takagawa, Y Kanno, ...Molecular and cellular biology 29 (23), 6232-6244, 2009200
94
2009
Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function
Y Kanno, A Ishisaki, E Kawashita, N Chosa, K Nakajima, T Nishihara, ...Journal of Biological Chemistry 286 (11), 8952-8960, 2011201
54
2011
The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis
Y KannoInternational Journal of Molecular Sciences 20 (3), E619, 2019201
45
2019
uPA attenuated LPS-induced inflammatory osteoclastogenesis through the plasmin/PAR-1/Ca2+/CaMKK/AMPK axis
Y Kanno, A Ishisaki, E Kawashita, H Kuretake, K Ikeda, O MatsuoInternational journal of biological sciences 12 (1), 63, 2016201
44
2016
Alpha2‐antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F2α synthesis through adipose triglyceride lipase/calcium‐independent …
Y Kanno, E Kawashita, A Kokado, K Okada, S Ueshima, O Matsuo, ...Arthritis & Rheumatism 65 (2), 492-502, 2013201
38
2013
Involvement of α2‐antiplasmin in dendritic growth of hippocampal neurons
E Kawashita, Y Kanno, H Asayama, K Okada, S Ueshima, O Matsuo, ...Journal of neurochemistry 126 (1), 58-69, 2013201
29
2013
Bovine milk lactoferrin induces synthesis of the angiogenic factors VEGF and FGF2 in osteoblasts via the p44/p42 MAP kinase pathway
K Nakajima, Y Kanno, M Nakamura, XD Gao, A Kawamura, F Itoh, ...Biometals 24, 847-856, 2011201
27
2011
α2-antiplasmin is associated with the progression of fibrosis
Y Kanno, E Kawashita, M Minamida, A Kaneiwa, K Okada, S Ueshima, ...The American journal of pathology 176 (1), 238-245, 2010201
27
2010
The antifibrotic effect of α2AP neutralization in systemic sclerosis dermal fibroblasts and mouse models of systemic sclerosis
Y Kanno, E Shu, H Kanoh, M SeishimaJournal of Investigative Dermatology 136 (4), 762-769, 2016201
24
2016
α2AP mediated myofibroblast formation and the development of renal fibrosis in unilateral ureteral obstruction
Y Kanno, E Kawashita, A Kokado, H Kuretake, K Ikeda, K Okada, ...Scientific Reports 4 (1), 5967, 2014201
23
2014
Correlation between albuminuria and spontaneous platelet microaggregate formation in type 2 diabetic patients
S Araki, H Matsuno, M Haneda, D Koya, Y Kanno, J Itho, A Kishi, K Isshiki, ...Diabetes care 32 (11), 2062-2067, 2009200
19
2009
Urokinase-type plasminogen activator receptor is associated with the development of adipose tissue
Y Kanno, H Matsuno, E Kawashita, K Okada, H Suga, S Ueshima, ...Thrombosis and haemostasis 104 (12), 1124-1132, 2010201
19
2010
The blocking of uPAR suppresses lipopolysaccharide‐induced inflammatory osteoclastogenesis and the resultant bone loss through attenuation of integrin β3/Akt pathway
Y Kanno, A Ishisaki, M Miyashita, O MatsuoImmunity, inflammation and disease 4 (3), 338-349, 2016201
17
2016
Prostaglandin E2 reverses aberrant production of an inflammatory chemokine by microglia from Sandhoff disease model mice through the cAMP-PKA pathway
E Kawashita, D Tsuji, M Toyoshima, Y Kanno, H Matsuno, K ItohPLoS One 6 (1), e16269, 2011201
17
2011
Altered behavior in mice with deletion of the alpha2-antiplasmin gene
E Kawashita, Y Kanno, K Ikeda, H Kuretake, O Matsuo, H MatsunoPLoS One 9 (5), e97947, 2014201
16
2014
The absence of uPAR attenuates insulin-induced vascular smooth muscle cell migration and proliferation
Y Kanno, A Kuroki, M Minamida, A Kaneiwa, K Okada, K Tomogane, ...Thrombosis research 123 (2), 336-341, 2008200
16
2008
uPA‐derived peptide, Å6 is involved in the suppression of lipopolysaccaride‐promoted inflammatory osteoclastogenesis and the resultant bone loss
Y Kanno, C Maruyama, A Matsuda, A IshisakiImmunity, inflammation and disease 5 (3), 289-299, 2017201
14
2017
α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis
Y Kanno, E Shu, H Kanoh, A Matsuda, M SeishimaArthritis Research & Therapy 19, 1-8, 2017201
12
2017
α2AP is associated with the development of lupus nephritis through the regulation of plasmin inhibition and inflammatory responses
Y Kanno, M Miyashita, M Seishima, O MatsuoImmunity, Inflammation and Disease 8 (3), 267-278, 2020202
11
2020

Referred From: https://scholar.google.com/citations?user=2BFGWxAAAAAJ&hl=en

Cited by
Citations 1277
h-index 21
i10-index 38
Recommended Journals
Open Access Journals